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ABSTRACT
PREP1 (PKNOX1) maps in the Down syndrome (DS)
criticalregionofchromosome21,isoverexpressedin
some DS tissues and might be involved in the DS
phenotype. By using fibroblasts from DS patients
and by overexpressing Prep1 in F9 teratocarcinoma
and Prep1
i/i MEF to single out the role of the protein,
we report that excess Prep1 increases the sensitivity
of cells to genotoxic stress and the extent of the
apoptosis directly correlates with the level of Prep1.
The apoptotic response of Prep1-overexpressing
cells is mediated by the pro-apoptotic p53 protein
that we show is a direct target of Prep1, as its
depletion reverts the apoptotic phenotype. The
induction of p53 overcomes the anti-apoptotic role
of Bcl-XL, previously shown to be also a Prep1
target, the levels of which are increased in Prep1-
overexpressing cells as well. Our results provide a
rationale for the involvement of PREP1 in the
apoptotic phenotype of DS tissues and indicate that
differences in Prep1 level can have drastic effects.
INTRODUCTION
Prep1 belongs to the TALE class of homeodomain
proteins and is essential for embryonic development.
The human gene is referred to in the databases as
PKNOX1; however, since this symbol is misleading it
was suggested to name it PREP1 (1). In particular,
Prep1 null mouse embryos die before gastrulation
(Fernandez,L.C. and Blasi,F., manuscript in preparation),
while 75% of the hypomorphic Prep1
i/i embryos, that
express 2–3% of Prep1 mRNA and up to 10% of the
protein, show leaky embryonic lethality with defects in
angiogenesis, hematopoiesis and eyes development.
The other 25% live a normal-length life with major
anomalies (2,3).
Prep1 is a transcription factor that, in combination with
its major partners, Pbx proteins, regulates the overall size
of the organism and individual organs as well as major
developmental pathways. Indeed, hypomorphic Prep1
i/i
embryos and mice are much smaller and have also
smaller organs, for example, pancreatic islets and fetal
liver (2,4). Importantly, at least some of the phenotypes
of Prep1
i/i mice are also observed in the heterozygous
state (4).
An important aspect of the Prep1
i/i phenotype is the
strong spontaneous apoptosis observed in E9.5 and
E11.5 embryos, reproduced in E14.5 Prep1
i/i mouse
embryo ﬁbroblasts (MEFs), which are also more sensitive
to genotoxic stress (5).
The balance of pro- and antiapoptotic proteins at the
mitochondrial outer membrane regulates its permeability,
thus maintaining the organelle’s homeostasis and
cotrolling apoptosis (6,7). The antiapoptotic Bcl-x gene
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gene product (Bcl-XL) are downregulated in Prep1
i/i MEF
and fetal liver cells. Indeed, Prep1
i/i MEF have a
compromised mitochondrial membrane potential, and
show increased spontaneous and genotoxic stress-induced
apoptosis, that are rescued by re-introduction of the
Bcl-x gene (5).
Down syndrome (DS) is a human genetic disease due to
trisomy of chromosome 21 that causes a distinctive
phenotype with mental retardation, bone, blood and
immune defects (8). The neurodegenerative and immune
defects of DS patients correlate with an increased
apoptosis rate (8–11), which was linked to increased
expression of the proapoptotic tumor suppressor p53
(12,13).
PREP1 maps on chromosome 21 (21;q22.3) in humans
and chromosome 17 in mice (14) and is overexpressed
1.5-fold in brain tissues of DS patients (15). The
presence of PREP1 in the DS critical region of chromo-
some 21 (14) suggests that Prep1 might be involved in the
phenotype of DS. However, the abnormally high
apoptosis observed in embryos and MEF with reduced
levels of Prep1 (Prep1
i/i) (5) are in apparent discrepancy
with the increased apoptosis of Prep1-overexpressing DS
tissues (8,10–12).
We now report that the overexpression of Prep1 in
Prep1
i/i MEF and F9 teratocarcinoma cells (16), as well
as human DS ﬁbroblasts, also causes an increased sensiti-
zation to genotoxic stress in a p53-dependent manner,
unlike hypomorphic Prep1
i/i cells where apoptosis is
mainly due to Bcl-XL depletion (5). Indeed, p53
is a direct transcriptional target of Prep1, is upregulated
in Prep1-overexpressing cells and its downregulation in
these cells prevents apoptosis. This shows that a correct
balance of Prep1 is important in apoptotic homeostasis, as
both its absence (5) and its overexpression induce
apoptosis, although through diverse molecular
targets: Bcl-x or p53.
MATERIALS AND METHODS
Cell culture
Human skin ﬁbroblasts from spontaneous abortions
(between 14 and 21 weeks of gestation) of normal and
DS aﬀected feti were provided by Dr. Franca Dagna
Bricarelli (Galliera Genetic Hospital, Genoa) after
karyotyping and maintained in RPMI medium supple-
mented with 10% of bovine fetal serum, 5mM sodium
pyruvate, 2mM glutamine and streptomycin/penicillin at
37 C in a humidiﬁed incubator with 5% CO2. Primary
Prep1
i/i MEFs were obtained from 14.5-day embryos,
after mating Prep1
+/i heterozygous animals and
genotyping and maintained as described elsewhere (5).
Murine F9 teratocarcinoma (16) and Cos7 cells were
maintained in Dulbecco’s modiEed Eagle’s medium
(DMEM) supplemented with 10% of bovine fetal serum,
5mM sodium pyruvate, 2mM glutamine and streptomy-
cin/penicillin at 37 C in a humidiﬁed incubator with
5% CO2.
Apoptotic treatments
3 10
5 MEF at passage 3 (5) and human skin ﬁbroblasts,
were plated in 6-cm dishes for ﬂuorescence-activated cell
sorting (FACS) analysis or at a density of 1 10
6 cells in
10-cm dishes for biochemical analysis. 6 10
5 F9 cells
were plated in 6-cm dishes for FACS analysis or at a
density of 2 10
6 cells in 10-cm dishes for biochemical
analysis. After 24h, each cell line was exposed to UV C
(254nm) at 1000J/m
2 (Vilber Lourmat, VL-115.C) or at
60J/m
2 (UV Stratalinker
TM 1800,Stratagene,) or treated
with etoposide (Sigma) as indicated in the ﬁgures and
previously described (5).
Flow cytometry
Apoptosis was measured with the Annexin V-FITC
Apoptosis Detection KIT II (BD Pharmingen, San
Diego, CA, USA) and analyzed by ﬂow cytometry
(FACSCAN, Becton–Dickinson).
Protein extraction and immunoblotting
Total cell extracts were prepared in RIPA buﬀer, clariﬁed
by centrifugation and quantitated as described in ref. 5.
Protein extracts were fractionated by sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
and transfered to polyvinylidene diﬂuoride (PVDF,
Millipore). Membranes were incubated with primary
antibodies for 1h at room temperature and incubated
with a peroxidase-conjugated secondary antibody for 1h
at room temperature. The ECL kit (Pierce, Rockford, IL,
USA) was used to detect peroxidase activity following the
manufacturer’s protocol. The resulting bands were
quantitated by densitometric analysis (Personal
Densitometer; Molecular Dynamics) as described (5).
Antibodies: p53 (monoclonal antibody; JM-3036-100;
MBL); Bcl-XL (monoclonal antibody; sc-8392;
SantaCruz Biotechnology); caspase-3 (polyclonal
antibodies; JM-3138-100; MBL); caspase-3 (polyclonal
antibodies; Cell Signaling Techonology, Danvers, MA,
USA); caspase-9 (monoclonal antibody; M054-3; MBL);
b-actin (polyclonal antibodies; sc-1616; SantaCruz
Biotechnology); tubulin-a (monoclonal antibody; N356;
Amersham Lifescience); Prep1 (Meis 4.1; monoclonal
antibody; 05-766; Upstate Biotechnology); and vinculin
(V9131 monoclonal antibody; Sigma). Pbx1b (monoclonal
antibody) was kindly provided by Dr. M. Cleary,
Department of Pathology, Stanford University School of
Medicine, Stanford, CA, USA.
Crude extracts used for the luciferase assay were
obtained using ‘Reporter Lysis Buﬀer 1 Solution’
(Promega; see below). The collected supernatants were
quantitated by the Bradford assay (Bio-Rad, Richmond,
USA), fractionated on SDS-PAGE and transferred to
PVDF (Millipore) as above.
RNA extraction, reverse transcription polymerase chain
reaction and quantitative PCR
For RNA extraction the ‘RNeasy mini Kit’ (Qiagen) was
used following the manufacturer’s instructions. Reverse
transcription (RT) on total RNA was carried out with
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TM First-Strand Synthesis System for
RT-PCR’ Kit (Invitrogen) using poly-A
+ primers. For
semiquantitative RT-polymerase chain reaction (PCR),
100ng of cDNA were ampliﬁed with the following
murine-speciﬁc primers:
Fwd-p53: 50-CTTCCCAGCAGGGTGTCACGC-30;
Rev-p53: 50-GTGCTGTGACTTCTTGTAGATGGC-30;
Fwd-Bcl-XL:5 0-CCACCACCTCCTCCCCGACC-30;
Rev-Bcl-XL 50-GTACCGCAGTTCAAACTCATCGC-30;
Fwd-b-actin: 50-GGCATCCTGACCCTGAAGT-30;
Rev-b-actin: 50-CGGATGTCAACGTCACACTT-30.
PCR was carried out on GeneAmp PCR System 2400
(Perkin Elmer), using a pre-PCR step of 2min at 95 C
followed by 28 cycles of 1min at 95 C, 30s at 63 C and
1min at 72 C. PCR products were resolved on a 1.5%
agarose 1 TAE gel and visualized by EtBr staining.
Triplicate RT-PCR reactions were carried out on an
ABI/Prism 7900 HT Sequence Detector System (Applied
Biosystems) at the IFOM-FIRC services (Milan) using
5ng of the RT reaction; the following TaqMan Gene
Expression Assays (Applied Biosystems) were used:
murine BCL2L1 (NM_009743): Mm00437783_m1;
murine b-actin (NM_007393.1): Mm00607939_s1;
human TP53 (NM_000546): Hs00153349_m1; human
PKNOX1(NM_197976.1): Hs00231814_m1; human
b-actin (NM_001101.2): Hs99999903_m1.
Retroviral infection
Retroviral infection of MEF with pBabe-puro-Prep1
vectors was performed as described in ref. 5.
p-retro-Super vector containing a speciﬁc shRNA for
murine p53 or a scrambled sequence were kindly
provided by Dr. Silvia Soddu (Regina Elena Cancer
Institute, Rome). Vectors were transfected in Phoenix
packaging cells by the calcium phosphate method. Viral
supernatants were used to perform four rounds of infec-
tions on Prep1 overexpressing F9 Teratocarcinoma cells
after addition of 5mg of Polybrene (Sigma).
p53-shRNA sequence: 50-gatccccGTACATGTGTAAT
AGCTCCttcaagagaGGAGCTATTACACATGTA
Ctttttggaaa-30.
scrambled sequence: 50-gatccccCTATAACGCTCGAT
ATttcaagagaATATCGAGCGCCGTTATA
Gtttttggaaa-30.
Hairpin-forming sequences are in capital letters.
Luciferase assay
Cos7 cells were transfected (in triplicate) with the plasmids
described in Figure 5 using Lipofectamine 2000
(Invitrogen) following the manufacturer’s instructions.
Plasmids: the reporter vector driven by the p53 regulatory
region was provided by D. Reisman (17). The Prep1,
Pbx1b and CMV b-Gal (Invitrogen) vectors were
described previously (5,18). The mutated p53 promoter
was prepared with the QuickChange II XL Site-Directed
Mutagenesis Kit (Stratagene) using the following
primers: fwd: 50-cctttctaaagtggtattttagctaatgaggg-30; rev:
50-ccctcattagctaaaataccactttagaaagg-30.
Thirty hours after the transfection cells were washed
with phosphate-buﬀered saline (PBS) and lysed with
‘Reporter Lysis Buﬀer 1 Solution’ (Promega) following
the manufacturer’s protocol. The luciferase activity and
the colorimetric b-gal reaction were measured as
previously described in ref. 5.
Chromatin immunoprecipitation
Cross-linked chromatin was prepared from conﬂuent
MEF (at passage 4) as described (5,19). Brieﬂy, 20-mg
aliquots were incubated overnight with the appropriate
antibodies (see below) or without antibodies (mock
controls). The resulting material was processed as
described (19). Four microliters of immunoprecipitated
genomic DNA were ampliﬁed with primers spanning the
Prep1/Pbx binding site (primer set 1): P53FWD1:5 0-GGT
GGTGCGATACCAAGTATCTCG-30; P53REV1:5 0-GT
AAGTGGACCGCCACTGTTCTG-30 or with primers
amplifying the control region (not containing the Prep1/
Pbx binding site; primer set 2): P53FWD2:5 0-GCCTCCA
TTTCTTGCCCTCAACC-30; P53REV2:5 0-CGTGACAC
CCTGCTGGGAAGG-30.
Ampliﬁcation conditions were previously reported (19).
Antibodies used for ChIP: anti-Pbx1b, provided by Dr.
M. Cleary (Stanford University School of Medicine, CA,
USA); anti-Prep1 polyclonal antibodies (18); anti-uPAR
polyclonal antibodies, (20). Ampliﬁcation products were
fractionated on a 2% agarose gel in 1 TAE buﬀer and
visualized by EtBr staining.
RESULTS
DS human ﬁbroblasts express more Prep1 and are more
sensitive to genotoxic stress
PREP1 maps on chromosome 21 (14): its level is increased
in at least the brain of trisomy 21 DS patients (15). We
ﬁnd that in DS ﬁbroblasts, Prep1 mRNA (Figure 1A) and
protein (Figure 1B) are higher than in ﬁbroblasts of
normal donors (NDs), as expected. Several DS tissues
are characterized by high levels of apoptotic cells
(8,10–12); we, therefore, estimated the level of apoptosis
of DS versus ND ﬁbroblasts by measuring the relative
amount of Annexin V-binding (ﬂow-cytometry) cells
after treatment with etoposide or UV-irradiation, both
of which cause genotoxic stress. Figure 1C shows that
untreated ND and DS ﬁbroblasts have the same level of
spontaneous apoptosis. However, upon a 24-h treatment
with etoposide the number of apoptotic cells increased
more substantially in DS than ND ﬁbroblasts. The same
results were obtained 24h after UV irradiation (data not
shown). Similar results were obtained with three diﬀerent
lines of DS ﬁbroblasts. In agreement with this observa-
tion, the immunoblot of Figure 1D and its quantiﬁcation
show that after 24h of etoposide treatment (or 24h
post-UV irradiation; data not shown), the level of
endogenous active caspase 3 increases more sharply in
DS than ND ﬁbroblasts.
We then exploited the variability in Prep1 content of the
three lines of DS ﬁbroblasts (Figure 1E, upper panel; see
also the high standard deviation of Figure 1B) to correlate
the levels of endogenous Prep1 with the susceptibility to
genotoxic stress (Figure 1E, lower panel). Individual
Nucleic Acids Research, 2010,Vol.38, No. 11 3597cultures of ND and DS ﬁbroblasts were divided in two
aliquots: one was used to establish the endogenous
Prep1 level; the other was treated with etoposide
(200mM) for 24h and the percentage of Annexin
V-positive cells was measured by ﬂow cytometry. As
shown in Figure 1E, the relative amount of Annexin
V-positive cells correlates with the endogenous level of
Prep1, indicating that cells with a higher level of
endogenous Prep1 are more susceptible to genotoxic
stress.
Cells harboring an ectopic Prep1 expression vector
recapitulate the apoptotic phenotype of DS ﬁbroblasts
Many genes are present in the DS critical region of chro-
mosome 21 and several of them may contribute to the DS
phenotype (8). To single out the role of Prep1 in
sensitizing cells to genotoxic stimuli, we tested the eﬀect
of Prep1 overexpression on the apoptotic behavior of
murine teratocarcinoma (F9) cells (Figure 2A, left panel)
and of MEFs from WT or Prep1
i/i hypomorphic mutant
mice (5,16). Figure 2A shows that the number of annexin
V-positive cells was higher in Prep1-overexpressing than in
control F9 cells both after etoposide treatment (Figure 2A,
middle panel) and UV irradiation (Figure 2A, right panel).
In agreement with these observations, the quantitation
(Figure 2B) of an immunoblot analysis of endogenous
caspase 9 in F9-overexpressing versus control cells after
etoposide or UV irradiation (Supplementary Figure S1A)
showed a more substantial increase in the former
(Figure 2B). In addition, WT MEF overexpressing Prep1
displayed the same behavior (data not shown). Thus,
Prep1 overexpression sensitizes cells to genotoxic
stress-induced apoptosis.
We have shown that Prep1
i/i MEF (expressing <10% of
Prep1 protein) have a compromised mitochondrial
membrane potential and increased spontaneous and
induced apoptosis. Spontaneous apoptosis is rescued by
Prep1 overexpression (5).We now, surprisingly, ﬁnd that
Prep1 overexpression increases the sensitivity to genotoxic
stress. In fact, Prep1
i/i MEF retrovirally infected to
overexpress Prep1 show an increase of the endogenous
levels of caspase 3 following genotoxic stress, as detected
(Supplementary Figure S1B) and quantiﬁed (Figure 2C)
by immunoblotting analysis. A similar activation of
Figure 1. Down syndrome ﬁbroblasts show increased Prep1 levels and are more prone to genotoxic stress induced apoptosis. (A) Total mRNA
from normal (ND) and Down syndrome (DS) skin ﬁbroblasts was puriﬁed, retro-transcribed using a poly-A
+ primer, quantitative real-time PCR
analysis was performed using primers speciﬁc for human Prep1 (‘Material and Methods’ section) and the data normalized to b-actin mRNA values.
(B) The average of Prep1 protein levels from three ND and ﬁve DS lines was calculated from the densitometric analysis of several immunoblots
(data not shown). (C)N D( n=4) and DS (n=5) ﬁbroblasts were treated (or not) with etoposide for 24h. The number Annexin V-positive
(i.e. apoptotic) cells was measured by FACS and values were expressed as percentage of total events. (D) Levels of active caspase 3 were
detected by immunoblot with speciﬁc polyclonal antibodies using crude extracts from ND and DS ﬁbroblasts treated (or not) with etoposide for
24h at the concentrations indicated in the ﬁgure. The graph shows the results of the densitometric analysis, normalized to tubulin. C, untreated cells.
(E) Cultures of three ND and three DS ﬁbroblast lines were divided in two aliquots: one was treated with 200mM etoposide for 24h and the level of
apoptosis measured by FACS using Annexin V staining and normalized to the level of apoptosis in the relative ND line. The other aliquot was used
to determine the level of Prep1 in each line by immunoblot and densitometric analysis and normalized to the Prep1 level of the relative ND line. The
relative Prep1 levels were plotted against the relative number of Annexin V positive cells for each DS line. A value of 100 was arbitrarily given to the
Prep1 level and the number of Annexin V-positive cells in the three ND lines analyzed; therefore, a single ND value is reported in the graph.
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MEF (data not shown). However, spontaneous
(uninduced) apoptosis was not aﬀected by Prep1
overexpression in F9 cells (Figure 2A middle panel).
We conclude that overexpression of Prep1 in F9 cells
and Prep1
i/i MEF increases their sensitivity and response
to apoptotic (genotoxic) stimuli, similar to what observed
in human skin ﬁbroblasts from DS patients.
Prep1 overexpression, Bcl-x gene expression and apoptosis
We have previously shown that the Bcl-x gene is a target
of Prep1 and that its reduced expression in Prep1
i/i MEF
accounts for the increased spontaneous and genotoxic
stress-induced apoptosis (5). We then analyzed the
endogenous mRNA and protein levels of Bcl-XL.I n
Prep1-overexpressing F9 cells we ﬁnd that both levels
are increased (Figure 3A). The diﬀerence in the amount
of protein and mRNA is probably due to the existence of
post-transcriptional regulation, which has not been
investigated. Moreover, they remain unaltered following
genotoxic stress, whereas they increase in control cells
(Figure 3B). These results are in line with the levels of
spontaneous apoptosis being essentially identical in
control versus overexpressing cells (Figures 1C and 2A).
However, the increase in Bcl-XL is diﬃcult to reconcile
with the sensitization of Prep1-overexpressing cells to
genotoxic-stress-induced apoptosis.
Apoptosis in Prep1 overexpressing mouse cells and human
DS ﬁbroblasts is p53-dependent
We therefore measured the endogenous mRNA and
protein levels of the apoptosis-relevant protein p53 in
cells overexpressing Prep1. We ﬁnd that, in the absence
of genotoxic stress, the level of endogenous p53 mRNA
and protein are 5- and 4-fold, respectively, higher in
Prep1-overexpressing than control F9 cells (Figure 4A)
and in Prep1-overexpressing Prep1
i/i MEF (data not
shown). Similarly, q-PCR on polyA
+ RNA from
untreated ND versus DS ﬁbroblasts showed a 50%
higher content of p53 mRNA in the latter (Figure 4B),
while also the protein levels appeared increased
(Figure 4D; compare lane C in ND with lane C in DS).
Upon etoposide treatment, higher levels of p53 accumula-
tion (21,22) were detected in Prep1-overexpressing F9 cells
Figure 2. Prep1 overexpression induces a strong apoptotic response in murine cells (A; left) Total extracts from murine F9 teratocarcinoma cells
stably transfected with a Prep1-expressing or control vector (16) were resolved in an 8% SDS-PAGE and transferred to a PVDF membrane. The
endogenous amount of Prep1 was checked by immunoblotting using a speciﬁc monoclonal antibody and normalized to b-actin content. (Middle)
Cells were treated with etoposide as indicated or (Right) UV irradiated (UVC 254nm; 60J/m
2). After 24h of treatment or 24h post-UV irradiation
the number of AnnexinV-positive (apoptotic) cells was determined by FACS and plotted for overexpressing and control cells. Values are expressed as
percentages of total events. C, untreated cells. (B) After 12h of etoposide treatment (as indicated) or 12h post-UV irradiation (UV C 254nm;
60J/m
2), total cell extracts from Prep1-overexpressing or control F9 cells were resolved on 12% SDS-PAGE, transferred to a PVDF membrane and
active caspases 9 levels were determined by immunoblotting and densitometric analysis, using tubulin for normalization. The densitometric analysis
of the blot (Supplementary Figure S1A; one of three independent immunoblots is shown as representative experiment) is shown in the graph. (C)
MEF from Prep1
+/+ and Prep1
i/i embryos infected with a retroviral vector (pBABE) either empty or containing the cDNA for human Prep1 were
previously described [(5); Figure 6D]. Infected MEF were treated (or not) with etoposide (200mM) for 24h or irradiated with UV light (UV C
254 nm; 60J/m
2 or 1000J/m
2). Crude extracts were prepared after 24h of drug treatment or 12 (1000J/m
2) or 24h (60J/m
2) post-UV irradiation,
fractionated in 12% SDS-PAGE, transferred to a PVDF membrane and the level of active caspase-3 determined by densitometric analysis (shown in
the graph) of immunoblots (Supplementary Figure S1B). The experiment was repeated three times and the results from a representative experiment
are shown.
Nucleic Acids Research, 2010,Vol.38, No. 11 3599and MEF versus their relative control (Figure 4C and data
not shown, respectively) and also in DS versus ND
ﬁbroblasts (Figure 4D).
To conﬁrm that genotoxic-stress-induced apoptosis in
Prep1-overexpressing cells was indeed p53-dependent, we
knocked-down p53 expression with a speciﬁc siRNA
before subjecting them to treatment. Prep1-overexpressing
F9 cells were infected either with a retroviral vector
expressing a siRNA speciﬁcally targeted to p53 mRNA
(see ‘Materials and Methods’ section) or a scrambled
siRNA, as a control. The percentage of Annexin
V-positive cells, in response to 1-mM etoposide, was then
measured by ﬂow cytometry. The left panel of Figure 4E
shows the depletion of endogenous p53 protein obtained
by the speciﬁc siRNA in Prep1 overexpressing F9 cells.
When cells underwent genotoxic stress, p53-silenced
cells displayed the same level of apoptosis as untreated
cells, indicating that the Prep1-induced apoptosis is
p53-dependent (Figure 4E, right). On the other
hand scrambled siRNA-expressing cells showed an
increase in the level of apoptosis, as expected
(Figure 4E, right). We conclude, therefore, that Prep1
acts upstream of p53.
p53 is a transcriptional target of Prep1
We then investigated the possibility that Prep1 regulates
p53 gene transcription. The sequence upstream of the
murine p53 gene (17) contains two high aﬃnity
Prep1/Meis and Pbx canonical consensus sequences (TG
ACAT), as well as other low-aﬃnity sites (Figure 5A) (23).
We co-transfected COS cells with a luciferase reporter
plasmid driven by the p53 regulatory region (p53-Luc,
consisting of 1327bp upstream and 337bp downstream
of the p53 transcription start site), along with expression
vectors for Prep1 and Pbx1b, either alone or in combina-
tion. The p53-Luc reporter (17) had promoter activity of
its own (Figure 5B) and was only marginally activated
upon co-transfection with Prep1 or Pbx1b single expres-
sion vectors (data not shown). However, when the
p53-Luc reporter was co-transfected with both Prep1
and Pbx1b expression vectors we observed a 2.5-fold
increase in luciferase activity, indicating transcriptional
activation of the reporter. Mutation of one canonical
Prep1/Pbx binding sites in the regulatory region of the
reporter plasmid reduced the activation by Prep1/Pbx1b
heterodimer to almost basal levels, while causing a 30%
reduction of the basal promoter activity. The results
indicate that Prep1 and Pbx1 can indeed activate the p53
promoter.
We therefore asked whether a Prep1–Pbx1 complex was
present on the regulatory region of p53 by using
chromatin immunoprecipitation (ChIP). Since occupancy
of chromatin regions corresponding to the regulatory
elements of a given gene may be biased, in this kind of
experiments, by the overexpression of speciﬁc proteins, we
therefore decided to use MEF from WT and Prep1
i/i
hypomorphic mutant mice, using the latter cells as a
negative control. Cross-linked, sonicated chromatin from
the above cells was immunoprecipitated with antibodies
against Prep1 and Pbx1b. DNA puriﬁed from the
immunoprecipitates was analyzed by PCR amplifying
both the regulatory region, containing the putative
Prep1/Pbx binding sites, and the region immediately
downstream the start site, that does not contain any
canonical consensus-binding site (Figure 5A). PCR
products were fractionated on agarose gels and detected
by ethidium bromide staining. The results of Figure 5C
show that chromatin immunoprecipitated with Prep1 and
Pbx1b antibodies from WT (Figure 5C, upper +/+
panel), but not from Prep1
i/i MEF (Figure 5C; i/i panel),
is enriched in the p53 regulatory region, indicating the in
vivo binding of the Prep1/Pbx heterodimer. The lack of
enrichment in the immunoprecipitate from Prep1
i/i MEF
is a good control for the speciﬁcity of anti-Prep1 and
anti-Pbx1 antibodies: in fact, Prep1
i/i MEF also has a
major reduction of all Pbx proteins (data not shown).
No enrichment was detected in the downstream region
(control), lacking Prep1/Pbx-binding sites (Figure 5C,
bottom +/+ panel).
Overall, these results indicate that the p53 gene is a
transcriptional target of the Prep1/Pbx complex.
DISCUSSION
Previously reported observations (5) and the results shown
in this paper indicate that not only the absence of Prep1,
but also its overexpression bias cells toward apoptosis.
This appears incompatible, of course, unless the
Figure 3. Prep1 overexpression increases Bcl-XL expression (A; left)
Total RNA was puriﬁed from untreated Prep1-overexpressing or
control F9 cells, retrotranscribed using polyA
+ primers and
semiquantitative PCR analysis performed with speciﬁc primers for
murine Bcl-XL and b-actin. The results of the densitometric analysis
is shown under each lane. (Right) Crude extracts from the above cells
were resolved by 12% SDS-PAGE and transferred to PVDF
membrane. Endogenous Bcl-XL protein levels were analyzed by
immunoblotting with speciﬁc monoclonal antibody and b-actin was
used for normalization. Results of the densitometric analysis are
shown under each lane. (B) Total mRNA and crude extracts were
prepared and processed as above for qPCR (experiment performed in
triplicate; left) or immunoblotting (right) from cell that were treated (or
not) with the etoposide for 12h. A value of 1 and of 100 was arbitrarily
given to Bcl-XL mRNA (left) and protein (right) amount, respectively,
in untreated cells infected with the control vector.
3600 Nucleic Acids Research, 2010,Vol.38, No. 11mechanisms are diﬀerent in the two conditions. Indeed, we
show that two diﬀerent, although related, mechanisms are
operative in Prep1-depleted versus overexpressing cells.
Here, we show that Prep1 overexpression causes an
increase in genotoxic-induced, but not spontaneous
apoptosis. We also illustrate that genotoxic-induced
apoptosis is p53-dependent and that overexpression of
Prep1 directly increases the level of p53. Finally, we dem-
onstrate that a WT p53 reporter, but not a reporter
mutated in the Prep1–Pbx1 binding site, is activated by
the Prep1–Pbx1 heterodimer and that this complex binds
the p53 promoter of WT, but not Prep1
i/i MEF in vivo.
We have previously shown that in the absence of Prep1
Bcl-XL is decreased and that re-establishment of the
Bcl-XL level rescues the spontaneous and induced
apoptotic phenotype (5). In fact, we demonstrated that
Bcl-x is a direct target of Prep1 since a wild-type Bcl-x
reporter gene was activated by expression of a Prep1–Pbx1
Figure 4. Endogenous p53 expression levels increase in Prep1 overexpressing cells and its depletion rescues the apoptotic phenotype. (A; left) Total
RNA was puriﬁed from untreated Prep1-overexpressing or control F9 cells, retrotranscribed using polyA
+ primers and semiquantitative PCR
analysis performed using speciﬁc primers for murine p53 and b-actin. Densitometric analysis results are shown under each lane. (Right) Crude
extracts from the above cells were fractionated by 12% SDS-PAGE and transferred to PVDF membrane. Endogenous p53 levels were analyzed by
immunoblotting with a speciﬁc monoclonal antibody. Tubulin was used for normalization. Densitometric analysis results are shown under each lane.
(B) Total mRNA form ND (n=3) and DS (n=4) ﬁbroblast lines was puriﬁed and processed as above. Quantitative real-time PCR was performed
using primers speciﬁc for human p53 and the data are normalized to b-actin mRNA values. (C) Prep1-overexpressing or control F9 cells were treated
with etoposide as shown or irradiated with UV C (254nm; 60J/m
2). After 12h of treatment or 12h post-irradiation, crude extracts were prepared,
resolved by 12% SDS-PAGE and transferred in PVDF membrane. The amount of p53 protein was determined by immunoblotting using a speciﬁc
monoclonal antibody and the value normalized to tubulin. The graph reports the representative results of the above immunoblot (from one of three
independent experiments), which was exposed for a short time to maintain p53 in the linear range for most of the lanes and in which p53 is not
visible either in the C or 1-mM lanes. However, a longer exposure of the same blot shows the presence of p53 in the relevant C and 1-mM lanes
(Supplementary Figure S1C). (D) Crude extracts were prepared from ND and DS ﬁbroblasts treated (or not) with etoposide for 24h, as indicated,
fractionated and transferred as above. The levels of p53 were determined by densitometric analysis of the immunoblot, performed using speciﬁc
monoclonal antibody and normalized to tubulin. C, untreated cells. The representative results of one of three independent experiments (using
diﬀerent ND and DS ﬁbroblast lines) are shown. (E; left) Prep1 overexpressing F9 cells were infected with p-retro-super vector containing either
a p53-speciﬁc or scrambled sequence shRNA and the level of endogenous p53 protein was detected from an aliquot of cells by immunoblotting using
a monoclonal antibody and quantitated by densitometry and normalized to b-actin content. (Right) Another aliquot of knocked down or control
Prep1-overexpressing F9 cells was treated with etoposide (1mM) for 24h and apoptotic cells were detected by ﬂow cytometry using Annexin-V
staining and their number plotted. The values were expressed as percentage of total events.
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binding site was not. Moreover, we showed by ChIP that
Prep1 and Pbx1 are bound to the Bcl-x promoter in
wild-type MEF, but not in Prep1
i/i MEF in vivo.
Therefore, the link between Prep1, Bcl-x expression and
apoptosis is straightforward: a decrease in Prep1 levels
leads to a decrease in Bcl-XL and altered mitochondrial
homeostasis, priming cells to a greater sensitivity to
genotoxic stress (5). On the contrary, when Prep1 is
overexpressed, the p53 gene takes over. However, this
appears dependent on the presence of genotoxic stress.
In fact, untreated cells have increased levels of both
Bcl-XL (as expected) and p53, but no Prep1-dependent
diﬀerence in spontaneous apoptosis. The absence of
diﬀerential apoptosis must signify that the two pro- and
anti-apoptotic proteins must be quantitatively balanced.
However, upon genotoxic stress of Prep1-overexpressing
cells, p53 overcomes Bcl-XL and the balance is tilted in
favor of the pro-apoptotic protein. This is most likely not
only due to the eﬀect of Prep1. Since Bcl-x gene expression
is transcriptionally repressed by p53 (24,25), we would like
to suggest that in overexpressing cells Prep1 activates both
the Bcl-x and p53 genes. However, the stronger activation
of p53 upon genotoxic stress leads to the repression of the
Bcl-x gene, thus tilting the balance toward apoptosis.
These results shed some light on the role of Prep1 in
regulating apoptosis. Although carried out in cell lines,
the newly discovered mechanisms explain the apoptotic
Figure 5. p53 expression is directly controlled by Prep1-Pbx complex. (A) Murine p53 gene regulatory region [M26862 (17)]. Putative Prep1-Meis/
Pbx-binding sites are in bold and in a larger font (low-aﬃnity sites are in bold with the same font as the rest of the sequence). The canonical sequence
is underlined and mutated bases are marked with an asterisk (A to G and C to T). The sequence in bold and italic is a canonical binding site on the
reverse strand. Sequences underlined and with arrows are the primers used for the PCR ampliﬁcation of genomic DNA from ChIP (see below).
Primer set 1 (FWD1 and REV1) spans the region containing the Prep1/Pbx canonical binding site. Primer set 2 (FWD2 and REV2) spans the control
region not containing any Prep1/Pbx binding site. The transcription start site (T) is shown. (B) Luciferase activity, in arbitrary units, assayed from
extracts of transiently transfected Cos7 cells. The reporter (luciferase) vector containing either the WT (p53); (17)) or mutated (p53mut) regulatory
region (–1327/+337bp) of the murine trp53 gene [whole sequence shown in (A)] was co-transfected with Prep1 and/or Pbx1b expression vectors. The
graph shows the b-galactosidase-normalized luciferase activity of total cell extracts. (C) ChIP was performed as described in ‘Materials and Methods’
section. Cross-linked chromatin from Prep1
+/+ and Prep1
i/i MEF was immunoprecipitated with antibodies against Prep1, Pbx1b and uPAR (as
unrelated antibody). Ampliﬁcation was performed using a speciﬁc primer set for the trp53 regulatory or control region (containing or not the Prep1/
Pbx1-binding sites, respectively) and PCR products were fractionated on a 2% agarose 1 TAE gel and visualized by EtBr staining. The picture
shows a representative experiment out of three performed with the same outcome. mut: mutated.
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tion of prep1.1, and in Prep1
i/i embryos. The fact that until
now it has not been possible to produce Prep1-transgenic
mice by oocyte injection is possibly due to a lethal eﬀect
(apoptosis) of Prep1 overexpression.
While increasing our knowledge on the molecular mech-
anisms underlying Prep1 phenotypes, the present results
give valuable information on the DS phenotype. PREP1
in fact, maps on chromosome 21q23, i.e. in the DS critical
region (14). In DS patients, Prep1 protein is overexpressed
at least in the brain, where it over-activates the FABP7
gene (15). It is now well established that many tissues of
DS patients present an excess apoptosis (8,10–12). We
show here that ﬁbroblasts from DS patients have a
higher level of Prep1 and increased apoptosis when
compared with ND ﬁbroblasts. Moreover, the extent of
apoptotic response to genotoxic stress directly correlates
with the level of Prep1. These data suggest that Prep1 may
be deeply involved in the apoptotic phenotype of DS
tissues.
The rather strong diﬀerences between cells that do not
drastically diﬀer in Prep1 content recapitulate, however,
similar eﬀects observed in mouse embryos. Indeed, while
Prep1
–/– null embryos (i.e. 0% mRNA and protein) die
before gastrulation at E7.5 (Fernandez and Blasi, sub-
mitted), Prep1
i/i embryos (which express 2% mRNA and
4–10% protein) (2,4) die at E17.5 or survive (25%; see
above). Finally, double heterozygous Prep1
+/i–Prep1
+/–
embryos (which presumably express about 1% of the
mRNA) die at an intermediate age (Rowan, Blasi and
Maas, unpublished data). Therefore, minor diﬀerences in
Prep1 level can have drastic eﬀects.
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